Investor InsightsMore articles
Smarter Trading 26 Apr 2017
New advanced ETF & mFund filters
Insights 26 Apr 2017
Medical Marijuana: Don’t Inhale
The surge in valuations means medical marijuana stocks have gone from a standing start just over 24 months ago, to being valued between $27m and $190m, with the whole sector valuation approaching $1bn despite the lack of a revenue track record. Is this sustainable?
Insights 14 Mar 2017
Dividend darlings: future brightens for yield stocks
Over the long term, much of the returns from the Australian sharemarket have been through dividends. When reinvested, the power of compounding can see returns snowball over time.